Where The Selling Ran Deepest: 16 Stocks At 52-Week Lows
A short list of market laggards features some surprisingly large and growing businesses.
As of Tuesday, July 14, 16 stocks from the Russell 3000 are trading at their 52-week lows. This small group of decliners is notable given the S&P 500 has returned +1.9% over the last month. The list includes Oracle (ORCL), a company with a market value of about $367.8 billion, whose stock has declined 30.3% over the last month.
The central question is what to make of established companies, including 5 of the 16 names that are S&P 500 members, hitting new lows while the market trends positive. The full list follows.
Tuesday’s Full 52-Week-Low List
Here are all 16 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| ORCL | $367.8 Bil | -2.7% | -9.3% | -30.3% | -43.9% |
| ISRG | $134.7 Bil | -6.8% | -11.2% | -8.1% | -25.9% |
| BSX | $63.3 Bil | -4.5% | -5.9% | -9.6% | -58.7% |
| LVS | $30.0 Bil | -2.4% | -2.8% | -11.5% | -8.3% |
| CSGP | $11.4 Bil | -3.8% | -7.3% | -15.2% | -67.6% |
| DLB | $4.6 Bil | -1.7% | -1.6% | -8.0% | -34.1% |
| GPOR | $2.8 Bil | -1.9% | -9.1% | -6.8% | -17.9% |
| CPRI | $2.0 Bil | -4.5% | -14.1% | -20.0% | -13.4% |
| LCID | $1.5 Bil | -16.2% | -22.9% | -10.6% | -79.8% |
| EOSE | $1.5 Bil | -1.4% | -9.5% | -30.8% | -7.3% |
| FMC | $1.3 Bil | -1.7% | -7.5% | -4.2% | -73.8% |
| PRCT | $1.1 Bil | -9.0% | -8.2% | -30.3% | -65.9% |
| KDK | $0.8 Bil | -2.8% | -10.7% | -26.2% | |
| AGNT | $0.7 Bil | -5.3% | -13.7% | -8.7% | -56.5% |
| AIAI | $0.7 Bil | -6.3% | -25.5% | -37.8% | |
| IMSR | $0.6 Bil | -0.7% | -10.3% | -26.0% |
Where is revenue growth meeting a new price low?
Oracle (ORCL) stands out, trading at 21.5 times trailing earnings while its revenue grew 17.4% over the last twelve months. A similar pattern appears in the Health Care Equipment sector. Boston Scientific (BSX) is also at a new low, yet its revenue grew 17.4% over the last twelve months. That company’s stock now has a free cash flow yield of 5.2%.
A low price is a question, not a conclusion.
A 52-week-low list is a screen for dislocation, not a directory of broken companies. A stock arrives here for one of two reasons: either its business has been genuinely damaged, or the market has marked down a functioning business. The disciplined move is to use this list as a starting point for research. Before reacting to the price, check the business.
If any of these names tempt you, resist buying a price alone. Our Buy the Dip screen asks the follow-up question that matters: which marked-down stocks still have the growth and cash generation to recover.
The Low List Is A Symptom. Own The Discipline Instead
Every stock on this list got here the same way: the market lost confidence faster than the business could defend itself. Some will earn that confidence back and some will not, and telling them apart name by name is unforgiving work.
That work is what the Trefis High Quality (HQ) Portfolio systematizes: about 30 quality businesses screened for the cash flow and balance-sheet strength that let a company fight through a bad year, sized and rebalanced by rules. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Read the list; own the discipline.